Julia Lewis
-
Study tracks new end-stage renal disease therapy
Researchers in Vanderbilt’s Division of Nephrology conducted a Phase 3 clinical trial to test the safety and efficacy of a new drug to treat patients with end-stage renal disease. Read MoreAug 7, 2014